Simplify Logo

Full-Time

Business Development Representative

Orange County

Posted on 7/25/2024

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing for heart disease

Data & Analytics
Hardware
AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$135k - $210kAnnually

+ Stock Options

Senior

Newport Beach, CA, USA

Category
Business Development
Business & Strategy
Required Skills
Sales
Salesforce
Requirements
  • Proven sales skills and track-record of sales achievement
  • Account development experience
  • Clinical/technical proficiency
  • Ability to develop relationships with key account stakeholders
  • Customer-focused mentality
  • Knowledge of cardiac patient pathways and diagnostic technology
  • Self-motivated with excellent problem-solving ability
  • Strong work ethic
  • Experience with Salesforce.com or similar CRM
Responsibilities
  • Work with key strategic HeartFlow accounts to drive growth and adoption of cCTA and FFRct clinical pathway
  • Facilitate cross-functional collaboration throughout the organization
  • Increase HeartFlow usage within designated key strategic accounts
  • Meet/exceed quota for strategic HeartFlow account
  • Educate customers on HeartFlow's value proposition
  • Promote/champion HeartFlow and build advocacy

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company's product offerings include the HeartFlow Analysis, which consists of various analyses like FFRCT, RoadMap, and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries including the US, UK, Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning and patient safety. The goal of HeartFlow is to improve cardiovascular care by providing advanced diagnostic tools that facilitate better treatment decisions.

Company Stage

Series F

Total Funding

$1.2B

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

6%

1 year growth

13%

2 year growth

17%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $215 million Series F funding round led by Bain Capital Life Sciences positions HeartFlow for significant growth and expansion.
  • HeartFlow's AI-enabled products, such as the RoadMap Analysis, enhance diagnostic accuracy and efficiency, potentially improving patient outcomes and physician workflows.
  • With coverage by 100% of Medicare and over 98% of commercial payers, HeartFlow's technology is widely accessible, increasing its adoption and market penetration.

What critics are saying

  • The cardiovascular care market is highly competitive, requiring continuous innovation to maintain a leading position.
  • Regulatory hurdles and the need for ongoing FDA clearances could delay product launches and market entry.

What makes HeartFlow unique

  • HeartFlow's non-invasive cardiac test offers a safer and more efficient alternative to traditional invasive procedures, setting it apart in the cardiovascular care market.
  • The company's comprehensive product portfolio, including FFRCT, RoadMap, and Plaque Analysis, provides a unique combination of anatomical and physiological visualization of coronary arteries.
  • HeartFlow's technology has received FDA clearance and is commercially available in multiple countries, ensuring a broad market reach and regulatory credibility.
INACTIVE